SearchSearch CalendarCalendar GalleryGalleryAuction-PortalAuctions GlobalGlobal Top-ListTopMembersMembers StatisticsStats
get your RSS-Feed
Language/Sprache:  Admin  
 Login: ChatChat (0) new User-MapUser-Mapsend Passwordsend Password RegisterRegister


Forum Overview » Beispiel-Kategorie / Example Category » Beispiel-Forum / Example Forum » Beispiel-Thema / Example Thread
Pages: (1) [1] »
Registration necessaryRegistration necessary
Beispiel-Thema / Example Thread
indiangenericpriceno Access no Access first Post cannot be deleted -> delete the whole Topic 
Group: Administrator
Level:


Posts: 1
Joined: 8/9/2024
IP-Address: saved
offline


Regorafenib Price is a targeted therapy medication used to treat certain types of cancer. It is primarily indicated for: Colorectal Cancer: Regorafenib is used to treat metastatic colorectal cancer that has progressed despite prior treatments. Gastrointestinal Stromal Tumors (GISTs): It’s used for GISTs that are unresectable or metastatic and have failed prior treatment with imatinib and sunitinib. Hepatocellular Carcinoma (HCC): Regorafenib is used for liver cancer that has progressed after treatment with sorafenib. Regorafenib works by inhibiting several kinases involved in tumor growth, angiogenesis (the formation of new blood vessels that feed tumors), and cancer cell survival. This multi-target approach helps to disrupt the tumor’s ability to grow and spread. Common side effects include fatigue, diarrhea, nausea, hypertension, and skin rashes. More severe effects can include liver issues, bleeding, and gastrointestinal perforation. Regular monitoring and dose adjustments are important to manage these potential side effects.


edited by indiangenericprice on 8/9/2024 11:42:34 AM
8/9/2024 11:35:22 AM    
Registration necessaryRegistration necessary
Pages: (1) [1] »
all Times are GMT +1:00
Thread-Info
AccessModerators
Reading: all
Writing: all
Group: general
none
Forum Overview » Beispiel-Kategorie / Example Category » Beispiel-Forum / Example Forum » Beispiel-Thema / Example Thread

.: Script-Time: 0.047 || SQL-Queries: 7 || Active-Users: 2,625 :.
Powered by ASP-FastBoard HE v0.8, hosted by cyberlord.at